trending Market Intelligence /marketintelligence/en/news-insights/trending/06F8CtJuy9g3nZGiHxSNfQ2 content esgSubNav
In This List

2 former UK pharmaceutical company execs set up new PE firm

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Banking Essentials Newsletter: 7th February Edition

Case Study

A Bank Outsources Data Gathering to Meet Basel III Regulations

Podcast

Private Markets 360° | Episode 8: Powering the Global Private Markets (with Adam Kansler of S&P Global Market Intelligence)


2 former UK pharmaceutical company execs set up new PE firm

Richard Anderson and Spencer Kerry, two former executives of U.K. pharmaceutical company Crawford Healthcare Ltd., launched a new healthcare-focused private equity firm, Private Equity News reported.

Impel Healthcare Catalyst will target U.K. healthcare companies valued at up to £50 million with the aim of entering the international market, primarily the U.S., according to the report.

The newly created firm, which is expected to announce its first deal in the week of Oct. 21, can also co-invest with other debt and equity funders, the report added.